Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b

miR-20b Suppresses Th17 Differentiation and the Pathogenesis of Experimental Autoimmune Encephalomyelitis by Targeting ROR t and STAT3

(2014) E. Zhu et al.   JOURNAL OF IMMUNOLOGY

Natalizumab in clinical practice: managing the risks, enjoying the benefits

(2014) O. Aktas   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis

(2013) Roopali Gandhi et al.   ANNALS OF NEUROLOGY

MicroRNA Expression Changes during Interferon-Beta Treatment in the Peripheral Blood of Multiple Sclerosis Patients

(2013) Michael Hecker et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

microRNA-17-92 Regulates IL-10 Production by Regulatory T Cells and Control of Experimental Autoimmune Encephalomyelitis

(2013) D. de Kouchkovsky et al.   JOURNAL OF IMMUNOLOGY

Comprehensive analysis of microRNA profiles in multiple sclerosis including next-generation sequencing

(2013) Andreas Keller et al.   Multiple Sclerosis Journal

Differential microRNA expression in blood in multiple sclerosis

(2013) Helle Bach Søndergaard et al.   Multiple Sclerosis Journal

Decreased circulating miRNA levels in patients with primary progressive multiple sclerosis

(2013) Chiara Fenoglio et al.   Multiple Sclerosis Journal

Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis

(2013) C. Warnke et al.   NEUROLOGY

Altered microRNA expression in B lymphocytes in multiple sclerosis

(2012) Claudia Sievers et al.   CLINICAL IMMUNOLOGY

miR-29ab1 Deficiency Identifies a Negative Feedback Loop Controlling Th1 Bias That Is Dysregulated in Multiple Sclerosis

(2012) K. M. Smith et al.   JOURNAL OF IMMUNOLOGY

MicroRNA regulation in experimental autoimmune encephalomyelitis in mice and marmosets resembles regulation in human multiple sclerosis lesions

(2012) Juliane Lescher et al.   JOURNAL OF NEUROIMMUNOLOGY

Regulated microRNAs in the CSF of patients with multiple sclerosis: A case-control study

(2012) A. Haghikia et al.   NEUROLOGY

Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity

(2011) Mireia Guerau-de-Arellano et al.   BRAIN

Publication guidelines for refereeing and reporting on animal use in experimental autoimmune encephalomyelitis

(2011) David Baker et al.   JOURNAL OF NEUROIMMUNOLOGY

Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS

(2011) Bianca Weinstock-Guttman et al.   JOURNAL OF NEUROLOGY

Sustained improvement in Expanded Disability Status Scale as a new efficacy measure of neurological change in multiple sclerosis: treatment effects with natalizumab in patients with relapsing multiple sclerosis

(2011) J Theodore Phillips et al.   Multiple Sclerosis Journal

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Glatiramer Acetate Treatment Normalizes Deregulated microRNA Expression in Relapsing Remitting Multiple Sclerosis

(2011) Anne Waschbisch et al.   PLoS One

Altered expression of miR-17-5p in CD4+lymphocytes of relapsing-remitting multiple sclerosis patients

(2010) Raija L. P. Lindberg et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Modulation of adult hippocampal neurogenesis during myelin-directed autoimmune neuroinflammation

(2010) Petra Huehnchen et al.   GLIA

Altered miRNA expression in T regulatory cells in course of multiple sclerosis

(2010) Giuseppe De Santis et al.   JOURNAL OF NEUROIMMUNOLOGY

MicroRNAs miR-17 and miR-20a Inhibit T Cell Activation Genes and Are Under-Expressed in MS Whole Blood

(2010) Mathew B. Cox et al.   PLoS One

Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites

(2010) Doron Betel et al.   GENOME BIOLOGY

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47

(2009) Andreas Junker et al.   BRAIN

MicroRNA miR-326 regulates TH-17 differentiation and is associated with the pathogenesis of multiple sclerosis

(2009) Changsheng Du et al.   NATURE IMMUNOLOGY

Differential Micro RNA Expression in PBMC from Multiple Sclerosis Patients

(2009) David Otaegui et al.   PLoS One

Regulation of HIF-1α and VEGF by miR-20b Tunes Tumor Cells to Adapt to the Alteration of Oxygen Concentration

(2009) Zhang Lei et al.   PLoS One

Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls

(2009) Andreas Keller et al.   PLoS One

VEGF-mediated disruption of endothelial CLN-5 promotes blood-brain barrier breakdown

(2009) Azeb Tadesse Argaw et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miRiad Roles for the miR-17-92 Cluster in Development and Disease

(2008) Joshua T. Mendell   CELL

Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters

(2008) Andrea Ventura et al.   CELL

T Cell Costimulation via the Integrin VLA-4 Inhibits the Actin-Dependent Centralization of Signaling Microclusters Containing the Adaptor SLP-76

(2008) Ken Nguyen et al.   IMMUNITY

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

(2008) Raija L.P. Lindberg et al.   JOURNAL OF NEUROIMMUNOLOGY

MicroRNAs: new regulators of immune cell development and function

(2008) David Baltimore et al.   NATURE IMMUNOLOGY

Microfluidic-based enzymatic on-chip labeling of miRNAs

(2008) Sonja Vorwerk et al.   New Biotechnology